Inter-fractional error and intra-fractional motion of prostate and dosimetry comparisons of patient position registrations with versus without fiducial markers during treatment with carbon-ion radiotherapy

被引:0
作者
Iwai, Yuma [1 ]
Mori, Shinichiro [2 ]
Ishikawa, Hitoshi [1 ]
Kanematsu, Nobuyuki [2 ]
Matsumoto, Shinnosuke [2 ]
Nakaji, Taku [2 ]
Okonogi, Noriyuki [1 ]
Kobayashi, Kana [1 ]
Wakatsuki, Masaru [1 ]
Uno, Takashi [3 ]
Yamada, Shigeru [1 ]
机构
[1] QST Hosp, Natl Inst Quantum Sci & Technol, Chiba, Japan
[2] Natl Inst Quantum Sci & Technol, Inst Quantum Med Sci, Dept Accelerator & Med Phys, Chiba 2638555, Japan
[3] Chiba Univ Hosp, Dept Radiol, Chiba, Japan
关键词
Prostate cancer; Carbon-ion radiotherapy; Fiducial marker; Intra-fractional error; Inter-fractional error; Dosimetry; INTENSITY-MODULATED RADIOTHERAPY; RADIATION-THERAPY; NATIONAL INSTITUTE; TRACKING; ANATOMY; SYSTEM; CANCER;
D O I
10.1007/s12194-024-00808-8
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
A few reports have discussed the influence of inter-fractional position error and intra-fractional motion on dose distribution, particularly regarding a spread-out Bragg peak. We investigated inter-fractional and intra-fractional prostate position error by monitoring fiducial marker positions. In 2020, data from 15 patients with prostate cancer who received carbon-ion beam radiotherapy (CIRT) with gold markers were investigated. We checked marker positions before and during irradiation to calculate the inter-fractional positioning and intra-fractional movement and evaluated the CIRT dose distribution by adjusting the planning beam isocenter and clinical target volume (CTV) position. We compared the CTV dose coverages (CTV receiving 95% [V95%] or 98% [V98%] of the prescribed dose) between skeletal and fiducial matching irradiation on the treatment planning system. For inter-fractional error, the mean distance between the marker position in the planning images and that in a patient starting irradiation with skeletal matching was 1.49 +/- 1.11 mm (95th percentile = 1.85 mm). The 95th percentile (maximum) values of the intra-fractional movement were 0.79 mm (2.31 mm), 1.17 mm (2.48 mm), 1.88 mm (4.01 mm), 1.23 mm (3.00 mm), and 2.09 mm (8.46 mm) along the lateral, inferior, superior, dorsal, and ventral axes, respectively. The mean V95% and V98% were 98.2% and 96.2% for the skeletal matching plan and 99.5% and 96.8% for the fiducial matching plan, respectively. Fiducial matching irradiation improved the CTV dose coverage compared with skeletal matching irradiation for CIRT for prostate cancer.
引用
收藏
页码:504 / 517
页数:14
相关论文
共 25 条
[21]   Prostate position relative to pelvic bony anatomy based on intraprostatic gold markers and electronic portal imaging [J].
Schallenkamp, JM ;
Herman, MG ;
Kruse, JJ ;
Pisansky, TM .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (03) :800-811
[22]   Feasibility of insertion/implantation of 2.0-mm-diameter gold internal fiducial markers for precise setup and real-time tumor tracking in radiotherapy [J].
Shirato, H ;
Harad, T ;
Harabayashi, T ;
Hida, K ;
Endo, H ;
Kitamura, K ;
Onimaru, R ;
Yamazaki, K ;
Kurauchi, N ;
Shimizu, T ;
Shinohara, N ;
Matsushita, M ;
Dosaka-Akita, H ;
Miyasaka, K .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 56 (01) :240-247
[23]   Improvement in toxicity in high risk prostate cancer patients treated with image-guided intensity-modulated radiotherapy compared to 3D conformal radiotherapy without daily image guidance [J].
Sveistrup, Joen ;
af Rosenschold, Per Munck ;
Deasy, Joseph O. ;
Oh, Jung Hun ;
Pommer, Tobias ;
Petersen, Peter Meidahl ;
Engelholm, Svend Aage .
RADIATION ONCOLOGY, 2014, 9
[24]   Preliminary result of carbon-ion radiotherapy using the spot scanning method for prostate cancer [J].
Takakusagi, Yosuke ;
Katoh, Hiroyuki ;
Kano, Kio ;
Anno, Wataru ;
Tsuchida, Keisuke ;
Mizoguchi, Nobutaka ;
Serizawa, Itsuko ;
Yoshida, Daisaku ;
Kamada, Tadashi .
RADIATION ONCOLOGY, 2020, 15 (01)
[25]   Carbon ion radiotherapy using fiducial markers for prostate cancer in Osaka HIMAK: Treatment planning [J].
Tsubouchi, Toshiro ;
Hamatani, Noriaki ;
Takashina, Masaaki ;
Wakisaka, Yushi ;
Ogawa, Atsuhiro ;
Yagi, Masashi ;
Terasawa, Ayumi ;
Shimazaki, Kazuyuki ;
Chatani, Masashi ;
Mizoe, Jun'etsu ;
Kanai, Tatsuaki .
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 2021, 22 (09) :242-251